Social Responsibility

Ovarian Cancer Australia calls for urgent action following the passing of two ambassadors

Health Industry Hub | January 13, 2020 |
[Total: 1    Average: 4/5]

Ovarian Cancer Australia was deeply saddened to hear of the passing of two of Australia’s most prolific ovarian cancer ambassadors – ABC Newcastle Broadcaster Jill Emberson and Queensland Young Australian of the Year Finalist Kristen Larsen.

Jill and Kristen passed away within days of each other, only 10 months after standing together at Parliament House calling for urgent funding. Both Jill and Kristen were instrumental in securing $20 million funding for ovarian cancer research and a further $15 million for clinical trials into gynaecological cancers in 2019.

Although it is the largest injection of government funding the sector has ever seen, the passing of Jill and Kristen within days of each other shows that more funding is desperately needed to improve ovarian cancer’s five-year survival rate which languishes at just 46%.

Acting CEO of Ovarian Cancer Australia Josy Shaw offered her deepest condolences to Jill and Kristen’s family and friends. “Both women showed great tenacity and vulnerability in their efforts to raise much needed funds and awareness. Although the funds secured will assist ovarian cancer researchers, hundreds of millions are needed to really make the impact needed to have any hope of saving lives. Ovarian cancer researchers have made more progress in the past two years than they have in the past two decades. We are seeing women with late stage ovarian cancer living longer. While this brings a lot of hope and promise, we need to have the significant funding other cancers have received to have any hope of saving women’s lives. Jill and Kristen had possibly the greatest impact we’ve ever seen at Ovarian Cancer Australia. Their positive impact and momentum will continue for years to come. Their advocacy and action has given so many women impacted by this insidious disease hope for the future,” Mrs Shaw concluded.

In 2019, over 1500 Australian women were diagnosed with ovarian cancer and it is estimated that more than 1000 will die from the disease. Ovarian cancer is the most lethal women’s cancer and the sixth most common cause of cancer death in Australia.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

Build thought leadership, differentiate your organisation and let us help you connect with the Australian Pharma, MedTech and Biotech industry professionals. To learn more about Health Industry Hub’s unique media solutions please contact us.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Social Responsibility

Social Responsibility and Community Engagement - World Cancer Day 2020

World Cancer Day 2020

Health Industry Hub | January 22, 2020 |

People across Australia will come together on 4 February to reduce the impact of cancer around the world. 2020 marks […]

More


News & Trends - Pharmaceuticals

Pharma Medical News - TGA reveals new regulatory science strategy 2020-2025

TGA reveals new regulatory science strategy 2020-2025

Health Industry Hub | January 22, 2020 |

New technologies such as gene therapies, other cell and tissue therapies, 3D-printing, and software as a medical device are transforming […]

More


Marketing & Strategy

Biopharma marketing - embracing change for growth

Biopharma marketing – embracing change for growth

Health Industry Hub | January 22, 2020 |

For years, biopharma companies have celebrated their “patient centricity”, yet only 35% of patient groups say that the industry is […]

More


News & Trends - Medical Technology

MedTech News - Medtronic to launch a game changer for patients with neurological disorders

Medtronic to launch a game changer for patients with neurological disorders

Health Industry Hub | January 22, 2020 |

Medtronic announced the CE Mark for Percept PC neurostimulator; it is the only Deep Brain Stimulation (DBS) system to be […]

More